Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2018: 156.09

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 10, Issue 1

Issues

Volume 10 (2015)

Insulin resistance and adipokine levels correlate with early atherosclerosis – a study in prediabetic patients

Bogdan Mircea Mihai
  • Discipline of Diabetes, Nutrition and Metabolic Diseases, First Medical Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Antoniu Octavian Petriș
  • Discipline of Internal Medicine and Cardiology, First Medical Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Didona Anca Ungureanu
  • Discipline of Biochemistry, Morpho-Functional Sciences Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Cristina Mihaela Lăcătușu
  • Discipline of Diabetes, Nutrition and Metabolic Diseases, First Medical Department, University of Medicine and Pharmacy ”Grigore T. Popa”, 16th Universității Street, 700115, Iași, Romania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-09-26 | DOI: https://doi.org/10.1515/med-2015-0003

Abstract

Cardiovascular risk of prediabetes is still subject to controversies. We analyzed the associations between insulin resistance, adipokines and incipient atherosclerosis estimated by intima-media thickness (IMT) in a cross-sectional study on 122 prediabetic subjects without clinical signs of atherosclerotic disease. Homeostasis model assessment of insulin resistance (HOMA-IR, calculated as fasting insulin × fasting plasma glucose / 22.5), adiponectin, leptin, leptin-to-adiponectin ratio, carotid and femoral IMT were evaluated. We also assessed other parameters related to insulin resistance and adipokines (HbA1c, anthropometric and lipid parameters), as they may also influence atherosclerosis. Carotid IMT was correlated to adiponectin and leptin-to-adiponectin ratio (all p < 0.05), but not with HOMA-IR or leptin, while femoral IMT showed no relationship with these factors. After adjusting for leptin, leptin-to-adiponectin ratio, triglycerides, HDL-cholesterol, cholesterol-to-HDL ratio, triglycerides-to-HDL ratio and HbA1c, IMT values became correlated with HOMA-IR. Adjustment for HOMA-IR induced the appearance of new correlations between adipokines and both IMT values. In conclusion, insulin resistance and adipokines seem related to IMT in prediabetic subjects without clinical signs of arterial obstruction.

Keywords: prediabetes; insulin resistance; adiponectin; leptin; intima-media thickness

References

  • [1] International Diabetes Federation, IDF Diabetes Atlas, 6th ed., 2013, 7-11 Google Scholar

  • [2] Danaei G., Lawes C.M., Vander H.S., Murray C.J., Ezzati M., Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment, Lancet, 2006, 368, 1651-1659 Google Scholar

  • [3] Ford E.S., Zhao G., Li C., Pre-diabetes and the risk for cardiovascular disease. A systematic review of the evidence, J. Am. Coll. Cardiol., 2010, 55, 1310-1317 CrossrefGoogle Scholar

  • [4] Yadav A., Kataria M.A., Saini V., Yadav A., Role of leptin and adiponectin in insulin resistance, Clin. Chim. Acta., 2013, 417, 80-84 Google Scholar

  • [5] van de Voorde J., Pauwels B., Boydens C., Decaluwé K., Adipocytokines in relation to cardiovascular disease, Metabolism, 2013, 62, 1513-1521 CrossrefGoogle Scholar

  • [6] Kim J.Y., Choi E.Y., Mun H.S., Min P.K., Yoon Y.W., Lee B.K., et al., Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines, Cardiovasc. Diabetol., 2013, 12, 140 CrossrefGoogle Scholar

  • [7] Lindberg S., Mogelvang R., Pedersen S.H., Bjerre M., Frystyk J., Flyvbjerg A., et al., Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study), Am. J. Cardiol., 2013, 111, 1139-1145 Google Scholar

  • [8] Carmina E., Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome, Front. Horm. Res., 2013, 40, 40-50 Google Scholar

  • [9] Bidulescu A., Liu J., Chen Z., Hickson D.A., Musani S.K., Samdarshi T.E., et al., Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans: the Jackson Heart Study, Front. Public. Health., 2013, 1, 16 Google Scholar

  • [10] Watanabe T., Sato K., Itoh F., Wakabayashi K., Shichiri M., Hirano T., Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease, Sensors, 2012, 12, 4974-4985 CrossrefGoogle Scholar

  • [11] Gilardini L., Pasqualinotto L., Di Matteo S., Caffetto K., Croci M., Girola A., et al., Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity, Obesity (Silver Spring), 2011, 19, 1684-1689 CrossrefGoogle Scholar

  • [12] Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., et al., Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011, Cerebrovasc. Dis., 2012, 34, 290-296 Google Scholar

  • [13] Dullaart R.P., Kappelle P.J., Dallinga-Thie G.M., Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome, Atherosclerosis, 2010, 211, 393-396 Google Scholar

  • [14] Juonala M., Saarikoski L.A., Viikari J.S., Oikonen M., Lehtimäki T., Lyytikäinen L.P., et al., A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study, Atherosclerosis, 2011, 217, 234-239 Google Scholar

  • [15] World Health Organization & International Diabetes Federation, Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, WHO Press, Geneva, 2006, 1-36 Google Scholar

  • [16] Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L.Jr., et al., and the National High Blood Pressure Education Program Coordinating Committee, Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, Hypertension, 2003, 42, 1206-1252 CrossrefGoogle Scholar

  • [17] Jellinger P.S., Smith D.A., Mehta A.E., Ganda O., Handelsman Y., Rodbard H.W., et al., and the AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis., American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis, Endocr. Pract., 2012, 18, 1-78 CrossrefGoogle Scholar

  • [18] Redberg R.F., Vogel R.A., Criqui M.H., Herrington D.M., Lima J.A., Roman M.J., 34th Bethesda Conference, Task force #3, What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?, J. Am. Coll. Cardiol., 2003, 41, 1886-1898 Google Scholar

  • [19] Faeh D., William J., Yerly P., Paccaud F., Bovet P., Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity, Cardiovasc. Diabetol., 2007, 6, 32, DOI: 10.1186/1475-2840-6-32 CrossrefGoogle Scholar

  • [20] Vaudo G., Marchesi S., Siepi D., Brozzetti M., Mannarino M.R., Pirro M., et al., Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries, Metabolism, 2007, 56: 541-546 CrossrefGoogle Scholar

  • [21] Doruk H., Mas M.R., Ateşkan U., Isik A.T., Sağlam M., Kutlu M., The relationship between age and carotid artery intima-media thickness, hemoglobin A1c in nondiabetic, healthy geriatric population, Arch. Gerontol. Geriatr., 2005, 41, 113-119 Google Scholar

  • [22] Fujisawa M., Okumiya K., Matsubayashi K., Hamada T., Endo H., Doi Y., Factors associated with carotid atherosclerosis in community-dwelling oldest elderly aged over 80 years, Geriatr. Gerontol. Int., 2008, 8, 12-18 CrossrefGoogle Scholar

  • [23] Juonala M., Kähönen M., Laitinen T., Hutri-Kähönen N., Jokinen E., Taittonen L., et al., Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study, Eur. Heart. J., 2008, 29, 1198-1206 CrossrefGoogle Scholar

  • [24] Hacihamdioğlu B., Okutan V., Yozgat Y., Yildirim D., Kocaoğlu M., Lenk M.K., et al., Abdominal obesity is an independent risk factor for increased carotid intima-media thickness in obese children, Turk. J. Pediatr., 2011, 53, 48-54 Google Scholar

  • [25] Maher V., O’Dowd M., Carey M., Markham C., Byrne A., Hand E., et al., Association of central obesity with early carotid intima-media thickening is independent of that from other risk factors, Int. J. Obes., 2009, 33, 136-143 CrossrefGoogle Scholar

  • [26] Luksiene D.I., Petkeviciene J., Jureniene K., Klumbiene J., Smalinskiene A., Tamosiunas A., Association between anthropometric indexes and cardiovascular risk factors, Cent. Eur. J. Med., 2011, 6, 411-417 Google Scholar

  • [27] Acevedo M., Krämer V., Tagle R., Corbalán R., Arnaíz P., Berríos X., et al., Total/HDL cholesterol ratio and non HDL cholesterol as predictors for increased intima media thickness, Rev. Med. Chil., 2012, 140, 969-976 Google Scholar

  • [28] Enomoto M., Adachi H., Hirai Y., Fukami A., Satoh A., Otsuka M., et al., LDL-C/HDL-C ratio predicts carotid intima-media thickness progression better than HDL-C or LDL-C alone., J. Lipids., 2011, DOI: 10.1155/2011/549137 CrossrefGoogle Scholar

  • [29] Kavazarakis E., Moustaki M., Gourgiotis D., Drakatos A., Bossios A., Zeis P.M., et al., Relation of serum leptin levels to lipid profile in healthy children, Metabolism, 2001, 50, 1091-1094 CrossrefGoogle Scholar

  • [30] Tungtrongchitr R., Pongpaew P., Phonrat B., Tribunyatkul S., Viroonudomphol D., Supawan V., et al., Serum leptin and lipid profiles in Thai obese and overweight subjects, Int. J. Vitam. Nutr. Res., 2001, 71, 74-81 Google Scholar

  • [31] Marso S.P., Mehta S.K., Frutkin A., House J.A., McCrary J.R., Kulkarni K.R., Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries, Diabetes Care, 2008, 31, 989-994 Google Scholar

  • [32] von Eynatten M., Hamann A., Twardella D., Nawroth P.P., Brenner H., Rothenbacher D., Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease, Clin. Chem., 2006, 52, 853-859 CrossrefGoogle Scholar

  • [33] Avramoglu R.K., Basciano H., Adeli K., Lipid and lipoprotein dysregulation in insulin resistant states, Clin. Chim. Acta., 2006, 368, 1-19 Google Scholar

  • [34] Ristic P., Bokonjic D., Zivkovic V., Jakovljevic V., Zdravkovic M., Pejovic J., et al., Subcutaneous adipose tissue measurements and better metabolic prediction, Cent. Eur. J. Med., 2013, 8, 237-243 Google Scholar

  • [35] Moriya M., Okumura T., Takahashi N., Yamagata K., Motomura W., Kohgo Y., An inverse correlation between serum leptin levels and hemoglobin A1c in patients with non-insulin dependent diabetes mellitus, Diabetes Res. Clin. Pract., 1999, 43, 187-191 Google Scholar

  • [36] Taghdir M., Djazayeri A., Djalali M., Eshraghian M., Rajab A., Yegane H.S., et al., Relationships of serum leptin concentration with insulin, glucose, HbA1c levels and insulin resistance in overweight post-menopausal diabetic women, ARYA Atheroscler. J., 2010, 5, 175-180 Google Scholar

  • [37] Hadaegh F., Shafiee G., Ghasemi A., Sarbakhsh P., Azizi F., Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran Lipid and Glucose Study, Diabetes Res. Clin. Pract., 2010, 87, 342-347 Google Scholar

  • [38] Zhang Y.F., Hong J., Zhan W.W., Li X.Y., Gu W.Q., Yang Y.S., et al., Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects, Clin. Endocrinol., 2006, 64, 153-157 CrossrefGoogle Scholar

  • [39] Marini M.A., Succurro E., Castaldo E., Cufone S., Arturi F., Sciacqua A., et al., Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria, Diabetes Care, 2012, 35, 1144-1149 Google Scholar

  • [40] Bansilal S., Farkouh M.E., Fuster V., Role of insulin resistance and hyperglycemia in the development of atherosclerosis, Am. J. Cardiol., 2007, 99, 6B-14B Google Scholar

  • [41] Muniyappa R., Lantorno M., Quon M.J., An integrated view of insulin resistance and endothelial dysfunction, Endocrinol. Metab. Clin. North. Am., 2008, 37, 685-711 CrossrefGoogle Scholar

  • [42] Oliveira C.S.V., Giuffrida F.M.A., Crispim F., Saddi-Rosa P., Reis A.F., ADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease?, Arq. Bras. Endocrinol. Metabol., 2011, 55, 446-454 CrossrefGoogle Scholar

  • [43] Hedblad B., Nilsson P., Janzon L., Berglund G., Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a crosssectional study in Malmo, Sweden, Diabet. Med., 2000, 17, 299-307 CrossrefGoogle Scholar

  • [44] de Lima Sanches P., de Mello M.T., Elias N., Fonseca F.A.H, de Piano A., Carnier J., et al., Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program, Hypertens. Res., 2011, 34, 232-238 CrossrefGoogle Scholar

  • [45] Viscogliosi G., Andreozzi P., Marigliano V., Associations of plasma glucose levels and traits of metabolic syndrome with carotid intima media thickness in nondiabetic elderly subjects: are they mediated by insulin resistance?, Metab. Syndr. Relat. Disord., 2013, 11, 41-45 CrossrefGoogle Scholar

  • [46] Finucane F.M., Luan J., Wareham N.J., Sharp S.J., O’Rahilly S., Balkau B., et al., European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group, Savage DB. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals, Diabetologia, 2009, 52, 2345–2349 CrossrefGoogle Scholar

  • [47] Pilz S., Horejsi R., Moller R., Almer G., Scharnagl H., Stojakovic T., et al., Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin., J. Clin. Endocrinol. Metab., 2005, 90, 4792-4796 CrossrefGoogle Scholar

  • [48] Lo J., Dolan S.E., Kanter J.R., Hemphill L.C., Connelly J.M., Lees R.S., et al., Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women., J. Clin. Endocrinol. Metab., 2006, 91, 1677-1682 CrossrefGoogle Scholar

  • [49] Kojima S., Funahashi T., Maruyoshi H., Honda O., Sugiyama S., Kawano H., et al., Levels of adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma., Thromb. Res., 2005, 115, 483-490 Google Scholar

  • [50] Perticone F., Maio R., Sciacqua A., Andreozzi F., Iemma G., Perticone M., et al., Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension, Diabetes, 2008, 57, 167–171 CrossrefGoogle Scholar

  • [51] Ridker P.M., Hennekens C.H., Buring J.E., Rifai N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women., N. Engl. J. Med., 2000, 342, 836-843 Google Scholar

  • [52] Nilsson P.M., Engström G., Hedblad B., Frystyk J., Persson M.M., Berglund G., et al., Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance, Arterioscler. Thromb. Vasc. Biol., 2006, 26, 2758-2762 CrossrefGoogle Scholar

  • [53] Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B., Plasma adiponectin levels and risk of myocardial infarction in men, JAMA, 2004, 291, 1730-1737 Google Scholar

  • [54] Dallinga-Thie G.M., Dullaart R.P.F., Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations?, Atherosclerosis, 2010, 208, 328–329 Google Scholar

  • [55] Ciccone M., Vettor R., Pannacciulli N., Minenna A., Bellacicco M., Rizzon P., et al., Plasma leptin is independently associated with the intima-media thickness of the common carotid artery, Int. J. Obes. Relat. Metab. Disord., 2001, 25, 805-810 CrossrefGoogle Scholar

  • [56] Norata G.D., Raselli S., Grigore L., Garlaschelli K., Dozio E., Magni P., et al., Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery, Stroke, 2007, 38, 2844–2846 CrossrefGoogle Scholar

  • [57] Kotani K., Sakane N., Saiga K., Kurozawa Y., Leptin:adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness, Diabetologia, 2005, 48, 2684–2686 Google Scholar

  • [58] Gast K.B., Tjeerdema N., Stijnen T., Smit J.W., Dekkers O.M., Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis, PLoS One, 2012, 7, e52036, DOI: 10.1371/journal.pone.0052036 CrossrefGoogle Scholar

  • [59] Mancini G.B.J., Dahlöf B., Díez J., Surrogate Markers for Cardiovascular Disease: Structural Markers, Circulation, 2004, 109, IV-22-IV-30, DOI: 10.1161/01.CIR.0000133443.77237.2f CrossrefGoogle Scholar

About the article

Received: 2014-01-14

Accepted: 2014-07-21

Published Online: 2014-09-26


Citation Information: Open Medicine, Volume 10, Issue 1, ISSN (Online) 2391-5463, DOI: https://doi.org/10.1515/med-2015-0003.

Export Citation

© 2015 Bogdan Mircea Mihai et al.. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ioana Hristov, Veronica Mocanu, Florin Zugun-Eloae, Luminita Labusca, Iustina Cretu-Silivestru, Teodor Oboroceanu, Crina Tiron, Adrian Tiron, Alexandrina Burlacu, Alin Constantin Pinzariu, Ioana Armasu, Radu Mircea Neagoe, Adrian Covic, Viorel Scripcariu, and Daniel Vasile Timofte
Lipids in Health and Disease, 2019, Volume 18, Number 1

Comments (0)

Please log in or register to comment.
Log in